Hypocretin (orexin) loss in Alzheimer's disease.

No abstract is available for this paper.

• Publication year

  2012

• Venue

  Neurobiology of Aging

• Publication date

  2012-08-01

• Fields of study

  Medicine, Psychology

• Identifiers
  DOI 10.1016/j.neurobiolaging.2011.03.014PMID 21546124
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Localized loss of hypocretin (orexin) cells in narcolepsy without cataplexy.

  2009cited by this paper
• Hypocretin/orexin disturbances in neurological disorders.

  2009cited by this paper
• Hypocretin and Melanin‐Concentrating Hormone in Patients with Huntington Disease

  2008cited by this paper
• Hypocretin (orexin) cell loss in Parkinson’s disease

  2007cited by this paper
• Hypocretin (orexin) loss in Parkinson's disease.

  2007cited by this paper
• DRD3 variant and risk of essential tremor

  2007cited by this paper
• Alzheimer Disease and Its Management: A Review

  2006cited by this paper
• REM sleep changes in rats induced by siRNA‐mediated orexin knockdown

  2006cited by this paper
• Pineal clock gene oscillation is disturbed in Alzheimer's disease, due to functional disconnection from the “master clock”

  2006cited by this paper
• The number of hypothalamic hypocretin (orexin) neurons is not affected in Prader-Willi syndrome.

  2005cited by this paper
• Hypocretin (orexin): role in normal behavior and neuropathology.

  2004cited by this paper
• Sleep disorders in Alzheimer's disease and other dementias.

  2004cited by this paper
• Relationship between CSF hypocretin levels and hypocretin neuronal loss.

  2003cited by this paper
• Effects of central hypocretin-1 administration on hemodynamic responses in young-adult and middle-aged rats.

  2003cited by this paper
• The Sleep Disorders Inventory: an instrument for studies of sleep disturbance in persons with Alzheimer's disease

  2003cited by this paper
• Presenile dementia syndromes: an update on taxonomy and diagnosis

  2002cited by this paper
• The role of cerebrospinal fluid hypocretin measurement in the diagnosis of narcolepsy and other hypersomnias.

  2002cited by this paper
• Hypothalamic NPY and agouti-related protein are increased in human illness but not in Prader-Willi syndrome and other obese subjects.

  2002cited by this paper
• Narcolepsy:Clinical Features, New Pathophysiologic Insights, and Future Perspectives

  2001cited by this paper
• Hypocretin (orexin) input to trigeminal and hypoglossal motoneurons in the cat: a double-labeling immunohistochemical study.

  2001cited by this paper
• CSF hypocretin/orexin levels in narcolepsy and other neurological conditions

  2001cited by this paper
• A mutation in a case of early onset narcolepsy and a generalized absence of hypocretin peptides in human narcoleptic brains

  2000cited by this paper
• Distribution of orexin neurons in the adult rat brain.

  1999cited by this paper
• Hypothalamic Hypocretin (Orexin): Robust Innervation of the Spinal Cord

  1999cited by this paper
• Hypothalamic Hypocretin (Orexin): Robust Innervation of the Spinal Cord

  1999cited by this paper
• Distribution of orexin neurons in the adult rat brain.

  1999cited by this paper
• Characteristics of Sleep Disturbance in Community-Dwelling Alzheimer's Disease Patients

  1999cited by this paper
• Neurons Containing Hypocretin (Orexin) Project to Multiple Neuronal Systems

  1998influential reference
• Comparison of β-protein/A4 deposits and Alz-50-stained cytoskeletal changes in the hypothalamus and adjoining areas of Alzheimer’s disease patients: amorphic plaques and cytoskeletal changes occur independently

  1998cited by this paper
• Staging of Alzheimer-related cortical destruction.

  1997cited by this paper
• Staging of Alzheimer-Related Cortical Destruction

  1997cited by this paper
• Circadian rhythms and the suprachiasmatic nucleus in perinatal development, aging and Alzheimer's disease.

  1992cited by this paper
• Sleep Problems and Institutionalization of the Elderly

  1991cited by this paper
• Alterations in the circadian rest-activity rhythm in aging and Alzheimer's disease.

  1990cited by this paper
• REM latency in Alzheimer's disease.

  1989cited by this paper
• NOCTURNAL SLEEP OF NARCOLEPTICS.

  1963cited by this paper

• Orexin signaling across the female lifespan: developmental, reproductive, and aging perspectives from humans and animal models.

  2026cites this paper
• Associations of Cerebrospinal Fluid Orexin‐A, Alzheimer Disease Biomarkers, and Cognitive Performance

  2025cites this paper
• Orexin/Hypocretin Modulates Neuroinflammatory Response to LPS in a Sex and Brain‐Region Specific Manner in Young Rats

  2025cites this paper
• Wakefulness regulation of memory encoding and retrieval: structure and activity

  2025cites this paper
• Alzheimer’s disease with depression: clinical characteristics and potential mechanisms involving orexin and brain atrophy

  2025cites this paper
• Orexin and Lifestyle Habits: A Meaningful Connection Among Nutrition, Physical Activity, and Sleep Pattern in Health and Diseases

  2025cites this paper
• Efficacy of acupuncture in ameliorating sleep disorders in patients with dementia: A systematic review and meta-analysis

  2025cites this paper
• The role of MICOS in modulating mitochondrial dynamics and structural changes in vulnerable regions of Alzheimer’s Disease

  2025cites this paper
• TDP-43 overexpression in the hypothalamus drives neuropathology, dysregulates metabolism and impairs behavior in mice

  2025cites this paper
• Hypothalamic imaging in Alzheimer's disease and Lewy body dementia: A systematic review and meta-analysis.

  2025cites this paper
• The orexin/hypocretin system in dementia-related neurological disorders: a double-edged sword in cognitive impairment

  2025cites this paper
• Neuroimaging in narcolepsy: a critical review of recent advances and future research directions

  2025cites this paper
• The Complexly Parcellated, Yet Quantitatively Reduced, Orexinergic/Hypocretinergic System of Humans

  2025influential citation
• Waking up to the evidence of pharmacological treatments used to manage sleep disorders in people with dementia and mild cognitive impairment-A scoping review.

  2025cites this paper
• Reduction of orexin-expressing neurons and a unique sleep phenotype in the Tg-SwDI mouse model of Alzheimer’s disease

  2025cites this paper
• Cerebrospinal-fluid Orexin-A levels in different neurocognitive disorders: a comparison study

  2025cites this paper
• Functional Plasticity of Orexin/Hypocretin Neurons Balances Stress States.

  2025cites this paper
• Compensatory enhancement of orexinergic system functionality induced by amyloid-β protein: a neuroprotective response in Alzheimer’s disease

  2025cites this paper
• The interaction between orexin, sleep deprivation and Alzheimer’s disease: Unveiling an Emerging Connection

  2025cites this paper
• The wake- and sleep-modulating neurons of the lateral hypothalamic area demonstrate a differential pattern of degeneration in Alzheimer’s disease

  2024cites this paper
• International Union of Basic and Clinical Pharmacology CXIV: Orexin Receptor Function, Nomenclature and Pharmacology

  2024cites this paper
• Contribution of changes in the orexin system and energy sensors in the brain in depressive disorder - a study in an animal model

  2024cites this paper
• Orexin Receptor Antagonists for the Prevention and Treatment of Alzheimer’s Disease and Associated Sleep Disorders

  2024cites this paper
• Glymphatic pathway: An emerging perspective in the pathophysiology of neurodegenerative diseases

  2024cites this paper
• Associations of sleep disorders with all-cause MCI/dementia and different types of dementia – clinical evidence, potential pathomechanisms and treatment options: A narrative review

  2024cites this paper
• The Role of Oxygen Homeostasis and the HIF-1 Factor in the Development of Neurodegeneration

  2024cites this paper
• Dual orexin receptor antagonist ameliorates sleep deprivation-induced learning and memory impairment in APP/PS1 mice.

  2024cites this paper
• Sex-dimorphic functions of orexin in neuropsychiatric disorders

  2024cites this paper
• CSF dynamics of orexin and β-amyloid42 levels in narcolepsy and Alzheimer's disease patients: A controlled study.

  2024cites this paper
• The Role and Mechanisms of the Hypocretin System in Zebrafish (Danio rerio)

  2024cites this paper
• Transcriptional Patterns in Stages of Alzheimer's Disease Are Cell-Type–Specific and Partially Converge with the Effects of Alcohol Use Disorder in Humans

  2024cites this paper
• Upsetting the Balance: How Modifiable Risk Factors Contribute to the Progression of Alzheimer’s Disease

  2024cites this paper
• The Aggravating Role of Failing Neuropeptide Networks in the Development of Sporadic Alzheimer’s Disease

  2024cites this paper
• Sex-specific hypothalamic neuropathology and glucose metabolism in an amyloidosis transgenic mouse model of Alzheimer’s disease

  2024cites this paper
• Baseline prepulse inhibition dependency of orexin A and REM sleep deprivation

  2024cites this paper
• Do orexin/hypocretin neurons track sensory, cognitive, or motor information?

  2023cites this paper
• Risk of neurodegenerative diseases in patients with sleep disorders: A nationwide population-based case-control study.

  2023cites this paper
• Hypothalamic orexins as possible therapeutic agents in threat and spatial memory disorders

  2023cites this paper
• Sleep and circadian rhythm disruption by NPTX2 loss of function

  2023cites this paper
• Targeting the orexin/hypocretin system for the treatment of neuropsychiatric and neurodegenerative diseases: from animal to clinical studies.

  2023cites this paper
• Rapid and precise genome engineering in a naturally short-lived vertebrate

  2023cites this paper
• Clinical usefulness of dual orexin receptor antagonism beyond insomnia: Neurological and psychiatric comorbidities.

  2023cites this paper
• Orexin pathway in Parkinson’s disease: a review

  2023cites this paper
• Narcolepsy—A Neuropathological Obscure Sleep Disorder: A Narrative Review of Current Literature

  2022cites this paper
• Sommeil et maladies neurodégénératives

  2022cites this paper
• Understanding the aging hypothalamus, one cell at a time.

  2022cites this paper
• What evidence is there for implicating the brain orexin system in neuropsychiatric symptoms in dementia?

  2022cites this paper
• Age- and alpha-Synuclein-Dependent Degeneration and Neurons in the Annual Killifish Nothobranchius

  2022cites this paper
• Sleep, Sirtuin 1 and Alzheimer’s disease: A review

  2022cites this paper
• Age- and alpha-Synuclein-Dependent Degeneration and Neurons in the Annual Killifish Nothobranchius

  2022cites this paper
• A molecular network map of orexin-orexin receptor signaling system

  2022cites this paper
• Age- and alpha-Synuclein-Dependent Degeneration and Neurons in the Annual Killifish Nothobranchius

  2022cites this paper
• Exploring cognitive and biological correlates of sleep quality and their potential links with Alzheimer’s disease (ALFASleep project): protocol for an observational study

  2022cites this paper
• Neurobiology of dream activity and effects of stimulants on dreams.

  2022cites this paper
• Ghrelin system in Alzheimer's disease.

  2022cites this paper
• Physiological Role of Orexinergic System for Health

  2022cites this paper
• Sleep duration, genetic susceptibility, and Alzheimer's disease: a longitudinal UK Biobank-based study

  2022cites this paper
• Title: “Genetic and chemical disruption of Amyloid Precursor Protein processing impairs zebrafish sleep maintenance”

  2022cites this paper
• The Involvement of Melatonin and Tasimelteon against Alzheimer's Disease.

  2022cites this paper
• Hippocampal orexin receptors: Localization and function.

  2022cites this paper
• Intracerebroventricular infusion of the selective orexin 1 receptor antagonist SB-334867 impairs cognitive flexibility in a sex-dependent manner.

  2022cites this paper
• A Bitter Experience That Enlightens the Future: COVID-19 Neurological Affection and Perspectives on the Orexigenic System

  2022cites this paper
• Rapid and precise genome engineering in a naturally short-lived vertebrate

  2022cites this paper
• Orexin A peptidergic system: comparative sleep behavior, morphology and population in brains between wild type and Alzheimer’s disease mice

  2022cites this paper
• Histological analysis of sleep and circadian brain circuitry in cranial radiation-induced hypersomnolence (C-RIH) mouse model

  2022cites this paper
• Age- and alpha-Synuclein-Dependent Degeneration and Neurons in the Annual Killifish Nothobranchius

  2022cites this paper
• Resetting the circadian clock of Alzheimer’s mice via GLP-1 injection combined with time-restricted feeding

  2022cites this paper
• Age- and alpha-Synuclein-Dependent Degeneration and Neurons in the Annual Killifish Nothobranchius

  2022cites this paper
• Association between Sleep, Alzheimer’s, and Parkinson’s Disease

  2021cites this paper
• The Normal Human Adult Hypothalamus Proteomic Landscape: Rise of Neuroproteomics in Biological Psychiatry and Systems Biology

  2021cites this paper
• The international classification of sleep disorders, third edition's classification of central disorders of hypersomnolence

  2021cites this paper
• Socioeconomic disparities in obstructive sleep apnea: a systematic review of empirical research

  2021cites this paper
• Orexinergic System in Neurodegenerative Diseases

  2021cites this paper
• Exploring the Role of Orexinergic Neurons in Parkinson’s Disease

  2021cites this paper
• Orexin-A in Patients With Lewy Body Disease: A Systematic Review and Meta-Analysis

  2021cites this paper
• Achieving brain clearance and preventing neurodegenerative diseases—A glymphatic perspective

  2021cites this paper
• Orexin A peptidergic system: Comparative physiology, morphology and population between brains of nomal and Alzheimer’s disease mice

  2021cites this paper
• The Role of Orexin in Alzheimer Disease: From Sleep-wake Disturbance to Therapeutic Target.

  2021cites this paper
• Cerebrospinal fluid orexin in Alzheimer's disease: a systematic review and meta-analysis.

  2021cites this paper
• Focus on the Complex Interconnection between Cancer, Narcolepsy and Other Neurodegenerative Diseases: A Possible Case of Orexin-Dependent Inverse Comorbidity

  2021cites this paper
• Discovery of Arylsulfonamides as Dual Orexin Receptor Agonists.

  2021influential citation
• Hypocretin/Orexin, Sleep and Alzheimer's Disease.

  2021cites this paper
• Sleep, Orexin and Cognition.

  2021cites this paper
• An overview of the orexinergic system in different animal species

  2021cites this paper
• Cerebrospinal Fluid Hypocretin and Nightmares in Dementia Syndromes

  2021cites this paper
• Pro-inflammatory interleukin-6 signaling links cognitive impairments and peripheral metabolic alterations in Alzheimer’s disease

  2021cites this paper
• Orexin a improves the cognitive impairment induced by chronic intermittent hypoxia in mice.

  2021cites this paper
• The orexin/hypocretin system in neuropsychiatric disorders: Relation to signs and symptoms.

  2021cites this paper
• Intranasal insulin and orexins to treat age-related cognitive decline.

  2021cites this paper
• Involvement of the Orexinergic System in Feeding

  2021cites this paper
• Polysomnographic assessment of suvorexant in patients with probable Alzheimer's disease dementia and insomnia: a randomized trial

  2020cites this paper
• The Lateral Hypothalamus: An Uncharted Territory for Processing Peripheral Neurogenic Inflammation

  2020cites this paper
• The hypocretin (orexin) system: from a neural circuitry perspective.

  2020cites this paper
• Brown Adipose Tissue: A Metabolic Regulator in a Hypothalamic Cross Talk?

  2020cites this paper
• Hypocretin (Orexin) Replacement Therapies

  2020cites this paper
• The Treatment of Sleep Dysfunction in Neurodegenerative Disorders

  2020cites this paper
• OREXIN AS A STRESS REGULATOR AND ITS RELATIONSHIP WITH COGNITION

  2020cites this paper
• Orexin-1 receptor blockade differentially affects spatial and visual discrimination memory facilitation by intracranial self-stimulation.

  2020cites this paper
• Counterbalanced microcircuits for Orx1 and Orx2 regulation of stress reactivity

  2020cites this paper
• Dysregulation of the orexin/hypocretin system is not limited to narcolepsy but has far‐reaching implications for neurological disorders

  2020cites this paper